We are live on ! Find out more

229 hedge funds and large institutions have $3.21B invested in Bruker in 2018 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 84 increasing their positions, 74 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more call options, than puts

Call options by funds: $327K | Put options by funds: $211K

24% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 33

14% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 74

4% more funds holding

Funds holding: 221229 (+8)

2.88% more ownership

Funds ownership: 66.28%69.17% (+2.9%)

7% less capital invested

Capital invested by funds: $3.47B → $3.21B (-$253M)

Holders
229
Holders Change
+8
Holders Change %
+3.62%
% of All Funds
5.1%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
41
Increased
84
Reduced
74
Closed
33
Calls
$327K
Puts
$211K
Net Calls
+$116K
Net Calls Change
+$384K

BRKR Hedge Fund Activity: Q4 2018 in Review

229 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Bruker (BRKR) for Q4 2018, worth a combined $3.21B — down 7.3% from $3.47B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new BRKR positions and 33 closed out — a net gain of 8 holders — while 84 added to existing stakes and 74 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $41.6M. The largest seller was OppenheimerFunds, cutting an estimated $44.3M.

  • 229 institutional investors held Bruker (BRKR) as of Q4 2018, up from 221 in Q3 2018.
  • Funds reported $3.21B of Bruker stock for Q4 2018, down 7.3% quarter-over-quarter.
  • 41 funds opened new Bruker positions in Q4 2018 and 33 closed out, a net change of +8 holders.
  • The largest Bruker buyer in Q4 2018 was Point72 Asset Management, an estimated $41.6M added.
  • The largest Bruker seller in Q4 2018 was OppenheimerFunds, an estimated $44.3M sold.

Based on aggregated 13F filings for Q4 2018.